ALLR - Why Is Nano-Cap Allarity Therapeutics Stock Trading Up On Thursday? | Benzinga
Allarity Therapeutics Inc (NASDAQ:ALLR) shares are trading higher on a strong session volume of 67 million, as per the data from Benzinga Pro.
The company announced the early discontinuation of its Phase 2 clinical trial of stenoparib for advanced recurrent ovarian cancer.
The patients enrolled in the trial had been pre-screened by Allarity’s Drug Response predictor (DRP) companion diagnostic to treat only patients with the highest likelihood of deriving clinical benefit.
The trial, evaluating stenoparib given twice daily, has ...